Microsoft word - cv-ml_engl_2pages10.doc

Prof. Dr. Michael Lanzer
Department of Infectious Diseases, Parasitology
Heidelberg University Medical School
69120 Heidelberg, Germany
Phone: +49-(0)6221-56 7845
Fax: +49-(0)6221-56 4643
E-mail: michael.lanzer@med.uni-heidelberg.de

CURRICULUM VITAE

2000
Offer for Professorship at the Seattle Biomedical Institute, USA (declined) Full Professor and Head of Department of Parasitology, University of Habilitation in Microbiology, University of Würzburg Junior Group Leader, Research Center for Infectious Diseases, University Postdoc, Sloan-Kettering Institute, New York, USA. PhD, Center for Molecular Biology, University of Heidelberg Diploma Thesis, Hoffman LaRoche und Co. AG, Basel, Switzerland Biology School, University of Heidelberg
COORDINATING FUNCTIONS

2005 – 2009
Member of the Executive Committee of the Marie-Curie Fellowship Member of the Executive Committee of the Network of Excellence Member of the Executive Committee of the European Malaria Graduate Co-chairman of the SFB 544 “Control of Tropical Infectious Diseases” Coordinator of various EU-funded research networks (6 in total)
HONORS
1995
Prize for Tropical Medicine, Awarded by the German Society for Tropical
FIELDS OF INTEREST

Molecular Parasitology, drug resistance mechanisms of the malarial parasite; antigenic
variation, cytoadherence, protein trafficking in P. falciparum, membrane transport processes:
CURRENTLY FUNDED PROJECTS

SFB544, project B12; EU-funded Network of Excellence EVIMalaR; EU-funded Integrated
Project AntiMal; EU-funded Marie Curie Fellowship Program InterMalTraining; EU-funded
infrastructure project Infravec, EU-funded Coordination and Support Action CRIMALDDI; EU-
funded Collaborative Project PreMalStruct; DFG-project on protein trafficking in Plasmodium
falciparum.

PUBLICATIONS (10 most important publications):

Rotmann A, Sanchez CP, Guigemde A, Rohrbach P, Dave A, Bakouh N, Planelles G, Lanzer
M (2010) PfCHA is a mitochondrial divalent cation/H+ antiporter in Plasmodium falciparum.
Mol Microbiol in press.
Kuhn Y, Sanchez CP, Ayoub D, Saridaki T, van Dorsselaer A, Lanzer M (2010) Trafficking of
the phosphoprotein PfCRT to the digestive vacuolar membrane in Plasmodium falciparum.
Traffic 11: 236-249.
Saridaki T, Frohlich KS, Braun-Breton C, Lanzer M (2009) Export of PfSBP1 to the
Plasmodium falciparum Maurer's clefts. Traffic 10: 137-152.
Saridaki T, Sanchez CP, Pfahler J, Lanzer M (2008) A conditional export system provides
new insights into protein export in Plasmodium falciparum-infected erythrocytes. Cell
Microbiol
10: 2483-2495.
Sanchez CP, Rotmann A, Stein WD, Lanzer M (2008a) Polymorphisms within PfMDR1 alter
the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Mol Microbiol 70:
786-798.
Sanchez CP, Stein WD, Lanzer M (2008b) Dissecting the components of quinine
accumulation in Plasmodium falciparum. Mol Microbiol 67: 1081-1093.
Kuhn Y, Rohrbach P, Lanzer M (2007) Quantitative pH measurements in Plasmodium
falciparum
-infected erythrocytes using pHluorin. Cell Microbiol 9: 1004-1013.
Sanchez CP, Rohrbach P, McLean JE, Fidock DA, Stein WD, Lanzer M (2007) Differences in
trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum.
Mol Microbiol 64: 407-420.
Rohrbach P, Sanchez CP, Hayton K, Friedrich O, Patel J, Sidhu AB, Ferdig MT, Fidock DA,
Lanzer M (2006) Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium
falciparum
. EMBO J 25: 3000-3011.
Przyborski JM, Miller SK, Pfahler JM, Henrich PP, Rohrbach P, Crabb BS, Lanzer M (2005)
Trafficking of STEVOR to the Maurer's clefts in Plasmodium falciparum-infected erythrocytes.
EMBO J 24: 2306-2317.

Source: http://www.cellnetworks.uni-hd.de/177937/cv_lanzer_michael.pdf

centronaval.org.ar2

El Licenciado en Relaciones Internacionales Christian Matías Machuca se graduó con Diploma de Honor en la Universidad del Salvador en 1997. Fue ayudante de cátedra de la materia "Estrategia" en dicha Universidad. Entre los años 1995 y 1996 realizó una pasantía universitaria en la Direc-ción de América del Sur del Ministerio de Relaciones Exteriores,ComercioInternacional y

Author:

OSTEOPOROSIS RISK FACTORS AND TREATMENT OPTIONS FACT SHEET What is osteoporosis? Osteoporosis is a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an increased susceptibility to fractures of the hip, spine and wrist. Wolff’s Law (1868) states that bone mass and density will be increased in areas of stress. Conversely

Copyright © 2010-2014 Internet pdf articles